Indian Journal of Sleep Medicine

Register      Login

VOLUME 16 , ISSUE 2 ( April-June, 2021 ) > List of Articles

CASE SERIES

Management and Long-term Follow-up of Severe Obstructive Sleep Apnea with Oral/Nasal Airway Dilator System—An “OASYS” of Possibilities

Oommen Nainan, Rahul Tyagi

Citation Information : Nainan O, Tyagi R. Management and Long-term Follow-up of Severe Obstructive Sleep Apnea with Oral/Nasal Airway Dilator System—An “OASYS” of Possibilities. Indian Sleep Med 2021; 16 (2):49-58.

DOI: 10.5005/jp-journals-10069-0073

License: CC BY-NC 4.0

Published Online: 13-07-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim and objective: This article aims to highlight the use of OAT (oral appliance therapy) with an oral/nasal airway dilator system in the treatment of patients with severe OSA, exhibiting non-tolerance with CPAP therapy. Background: CPAP is the gold standard for the treatment of OSA. CPAP treatment for OSA is only effective if the patient is cooperative and willing for the therapy. Unfortunately, due to the often uncomfortable and invasive nature of this treatment method, CPAP has a relatively low compliance rate, ranging from 40 to 70%. This is because CPAP has drawbacks, including discomfort from the mask, a dry or stuffy nose, and eye irritation. Case description: This article reports an interesting case of a 61-year old female with severe OSA and non-tolerance/non-compliance with the CPAP therapy, who was referred by the sleep physician to the orthodontic clinic for evaluation and advice concerning OAT for her OSA. Conclusion: Oral/Nasal Airway Dilator System (OASYS) works both as a nasal dilator and mandibular repositioner and acts by targeting multiple areas of the upper airway from the tip of the nose to the back of the throat. Clinical significance: OASYS stands out from the crowd of oral appliances by adding additional actions and targeting multiple areas of the airway with one convenient appliance and thus offers an effective means of treating severe OSA patients who are non-compliant with the CPAP therapy.


HTML PDF Share
  1. Sharma SK, Katoch VM, Mohan A, et al. for Indian initiative on obstructive sleep apnoea (INOSA) Guidelines working group. Consensus and evidence-based INOSA guidelines 2014 (First edition). Indian J Med Res 2014;140(3):451–468. PMID: 25366217 and PMCID: PMC4248396
  2. Kazumichi S, Tsuneya N. Review of systematic reviews on mandibular advancement oral appliance for obstructive sleep apnea: The importance of long-term follow-up. Jpn Dent Sci Rev 2020;56(1):32–37. DOI: 10.1016/j.jdsr.2019.10.002.
  3. Marklund M, Braem MJA, Verbraecken J. Update on oral appliance therapy. Eur Respir Rev 2019;28(153):190083. DOI: 10.1183/16000617.0083-2019.
  4. Singh GD, Abramson M. Effect of an intra-oral nasal dilation appliance on 3-D nasal airway morphology in adults. Sleep Breath 2008;12(1):69–75. DOI: 10.1007/s11325-007-0130-1.
  5. Iftikhar IH, Hays ER, Iverson MA, et al. Effect of oral appliances on blood pressure in obstructive sleep apnea: A systematic review and meta-analysis. J Clin Sleep Med 2013;9(2):165–174. DOI: 10.5664/jcsm.2420.
  6. Bartolucci ML, Bortolotti F, Martina S, et al. Dental and skeletal long-term side effects of mandibular advancement devices in obstructive sleep apnea patients: A systematic review with meta-regression analysis. Eur J Orthod 2019;41(1):89–100. DOI: 10.1093/ejo/cjy036.
  7. Otsuka R, Almeida FR, Lowe AA, et al. A comparison of responders and non responders to oral appliance therapy for the treatment of obstructive sleep apnea. Am J Orthod Dentofac Orthop 2006;129(2):222–229. DOI: 10.1016/j.ajodo.2004.06.035.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.